Sg Americas Securities, LLC Cti Biopharma Corp Transaction History

Sg Americas Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$4.45 - $6.17 $11,369 - $15,764	-2,555 Reduced 4.94%	49,149 $295,000
Q3 2022 Oct 31, 2022	SELL	$5.36 - $7.43 $278,821 - $386,501	-52,019 Reduced 50.15%	51,704 $301,000
Q2 2022 Jul 29, 2022	BUY	$3.55 - $6.27 $368,216 - $650,343	103,723 New	103,723 $619,000
Q3 2019 Nov 04, 2019	SELL	$0.64 - $0.92 $35,924 - $51,641	-56,132 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$0.8 - $1.03 $13,730 - $17,677	17,163 Added 44.04%	56,132 $48,000

Q1 2019 Apr 29, 2019	SELL	$0.9 - $1.37 $7,413 - $11,284	-8,237 Reduced 17.45%	38,969 $38,000
Q4 2018 Feb 01, 2019	BUY	$0.73 - $2.19 $34,460 - $103,381	47,206 New	47,206 $35,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.